|

Parkinson's Disease Clinical Trials in San Francisco, CA

22 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersPhase 1/2<1 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 4<1 mi
Ketamine for Veterans With Parkinson's DiseasePhase 2<1 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 2<1 mi
Parkinson's Foundation PD GENEration Genetic Registry—<1 mi
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)Phase 2<1 mi
Parkinson Progression Marker Initiative Online (PPMI Online)—<1 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—<1 mi
Psilocybin Therapy for Depression in Parkinson's DiseasePhase 2<1 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3<1 mi
Safety and Usability of the Cionic Neural Sleeve for Parkinson's DiseaseN/A<1 mi
Understanding Motivation in Parkinson's Patients Through NeurophysiologyN/A<1 mi
Blood Flow Restriction and Exercise in Parkinson's DiseaseN/A<1 mi
Exercise for Cognitive Excellence in Parkinson's DiseaseN/A<1 mi
Use of CereGate Therapy for Freezing of Gait in PDN/A22 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 228 mi
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseasePhase 228 mi
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsPhase 328 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—28 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease—28 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 428 mi
Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's DiseaseN/A28 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.